Reviewing BIO-key International (NASDAQ:BKYI) & Kopin (NASDAQ:KOPN)

BIO-key International (NASDAQ:BKYIGet Free Report) and Kopin (NASDAQ:KOPNGet Free Report) are both small-cap computer and technology companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, profitability, valuation, risk, institutional ownership, earnings and analyst recommendations.

Earnings and Valuation

This table compares BIO-key International and Kopin”s revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
BIO-key International $6.93 million 0.95 -$4.30 million ($1.04) -0.59
Kopin $50.33 million 8.27 -$43.88 million ($0.04) -57.00

BIO-key International has higher earnings, but lower revenue than Kopin. Kopin is trading at a lower price-to-earnings ratio than BIO-key International, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a breakdown of recent ratings for BIO-key International and Kopin, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BIO-key International 1 0 0 0 1.00
Kopin 1 0 4 0 2.60

Kopin has a consensus target price of $4.69, indicating a potential upside of 105.59%. Given Kopin’s stronger consensus rating and higher probable upside, analysts plainly believe Kopin is more favorable than BIO-key International.

Volatility and Risk

BIO-key International has a beta of 0.41, meaning that its stock price is 59% less volatile than the S&P 500. Comparatively, Kopin has a beta of 2.93, meaning that its stock price is 193% more volatile than the S&P 500.

Profitability

This table compares BIO-key International and Kopin’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
BIO-key International -70.23% -73.33% -43.89%
Kopin -13.81% -30.97% -9.76%

Insider and Institutional Ownership

26.5% of BIO-key International shares are owned by institutional investors. Comparatively, 31.0% of Kopin shares are owned by institutional investors. 3.7% of BIO-key International shares are owned by insiders. Comparatively, 2.8% of Kopin shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

Kopin beats BIO-key International on 11 of the 14 factors compared between the two stocks.

About BIO-key International

(Get Free Report)

BIO-key International, Inc. develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education customers in the United States and internationally. The company offers BIO-key PortalGuard and PortalGuard IDaaS solutions, a customer-controlled and neutral-by-design cloud-based identity platform that allows customers to integrate with any cloud or on-premises SaaS application, as well as windows device authentication through IAM platform. Its solutions enable its customers to secure their workforces and student populations; and make their partner networks more collaborative. In addition, it provides BIO-key VST and WEB-key products; and Civil and Large-Scale ID Infrastructure solutions that develops finger-based biometric technology. Further, it offers finger scanners for enterprise and consumer markets under SideSwipe, EcoID, and SidePass brand names. The company was formerly known as SAC Technologies and changed its name to BIO-key International, Inc. in 2002. BIO-key International, Inc. was founded in 1993 and is headquartered in Wall, New Jersey.

About Kopin

(Get Free Report)

Kopin Corporation, together with its subsidiaries, invents, develops, manufactures, and sells microdisplays, subassemblies, and related components for defense, enterprise, industrial, and consumer products in the United States, the Asia-Pacific, Europe, and internationally. It offers miniature active-matrix liquid crystal displays, liquid crystal on silicon displays/spatial light modulators, organic light emitting diode displays, microLED display technologies, application specific integrated circuits, backlights, and optical lenses; and head-mounted and hand-held VR products. The company’s products are used for soldier thermal weapon rifle sights, avionic fixed and rotary wing pilot helmets, armored vehicle targeting systems, and training and simulation headsets; industrial and medical headsets; 3D optical inspection systems; and consumer augmented reality and virtual reality wearable headsets systems. Kopin Corporation was incorporated in 1984 and is headquartered in Westborough, Massachusetts.

Receive News & Ratings for BIO-key International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BIO-key International and related companies with MarketBeat.com's FREE daily email newsletter.